NCT01205165View on ClinicalTrials.gov

An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)

PHASE4CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

December 17, 2004

Primary Completion Date

April 28, 2006

Study Completion Date

April 28, 2006

Conditions

Hepatitis B, Chronic

Interventions

DRUG

Adefor dipivoxil

All enrolled subjects were enrolled to adefovir dipivoxil arm.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY